From: Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
Fish servings (times/wk) | N 3900 | Plaque N (%) | Risk for plaque OR (95% CI) | TPAa mm2 (SE) |
---|---|---|---|---|
Total fish | ||||
< 1 | 258 | 124 (48.1) | 1.29 (0.95–1.74) | 2.17 (0.14) |
1–1.9 | 1325 | 594 (44.8) | 1 (Reference) | 2.01 (0.06) |
2–2.9 | 977 | 459 (47.0) | 0.86 (0.71–1.04) | 1.86 (0.07) |
≥ 3 | 1340 | 707 (52.8) | 1.01 (0.84–1.20) | 2.03 (0.06) |
p-trend | 0.4 | 0.7 | ||
Fatty fish | ||||
< 1 | 1841 | 832 (45.2) | 0.95 (0.82–1.11) | 1.94 (0.05) |
1–1.9 | 1518 | 738 (48.6) | 1 (Reference) | 1.99 (0.06) |
≥ 2 | 541 | 314 (58.0) | 1.20 (0.96–1.51) | 2.16 (0.10) |
p-trend | 0.06 | 0.07 | ||
Lean fish | ||||
< 1 | 330 | 163 (49.4) | 1.34 (1.03–1.76) | 2.18 (0.13) |
1–1.9 | 1437 | 652 (45.4) | 1 (Reference) | 1.99 (0.06) |
≥ 2 | 2133 | 1069 (50.1) | 0.93 (0.80–1.09) | 1.96 (0.05) |
p –trend | 0. 02 | 0.2 |